We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Why Even Targeted Therapies Eventually Fail in Lung Cancer

News   Mar 30, 2017 | Original story from Cold Spring Harbor Laboratory

 
Why Even Targeted Therapies Eventually Fail in Lung Cancer

Image courtesy Wikimedia Commons

 
 
 

RELATED ARTICLES

Circular RNAs Have Important Role in Innate Immunity

News

Scientists discovered that most examined circRNAs tend to form 16-26 bp intramolecularly imperfect RNA duplexes. In addition, circRNAs preferentially bind to dsRNA-activated protein kinase (PKR) which is related to innate immunity and act as PKR inhibitors.

READ MORE

Mission Bio Scales Executive Leadership Team With Three New Hires

News

Darrin Crisitello, Nigel Beard, and Marcel Roche join Mission Bio, bringing extensive experience in scaling advanced genomics technologies and markets to over $1 billion in revenue.

READ MORE

Fishing for Cures: Zebrafish Model Identifies Drugs That Kill Pediatric Cancer Cells

News

A new animal model developed by Massachusetts General Hospital (MGH) investigators promises to be less expensive, easier to use and to improve personalized therapies for cancers and potentially other diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE